학술논문
P081 - Oral relugolix for androgen deprivation therapy in advanced prostate cancer: Detailed safety analysis from the randomized phase 3 HERO study
Document Type
Abstract
Author
Source
In European Urology Open Science November 2022 45 Supplement 2:S156-S157
Subject
Language
ISSN
2666-1683